1-20 of 24
Laura J. van’t Veer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3678: Beyond detection: AI-based classification of breast cancer invasiveness using cell-free orphan non-coding RNAs

Mehran Karimzadeh, Taylor B. Cavazos, Nae-Chyun Chen, Noura K. Tbeileh, David Siegel, Amir Momen-Roknabadi, Jennifer Yen, Jeremy Ku, Selina Chen, Diana Corti, Alice Huang, Dang Nguyen, Rose Hanna, Ti Lam, Seda Kilinc, Philip Murzynowski, Jieyang Wang, Xuan Zhao, Andy Pohl, Babak Behsaz, Helen Li, Lisa Fish, Kim H. Chau, Marra S. Francis, Laura J. Van't Veer, Laura J. Esserman, Patrick A. Arensdorf, Hani Goodarzi, Fereydoun Hormozdiari, Babak Alipanahi
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3678.
https://doi.org/10.1158/1538-7445.AM2024-3678
Published: 22 March 2024
View articletitled, Abstract 3678: Beyond detection: AI-based classification of breast cancer invasiveness using cell-free orphan non-coding RNAs
Journal Articles

Abstract PS4-08: Biomarker analysis of paclitaxel, ganitumab, and metformin (PGM) therapy in the I-SPY2 neoadjuvant clinical trial

Douglas Yee, Paul Haluska, Denise M Wolf, Christina Yau, Amy Wilson, I-SPY2 TRIAL Consortium, Angela DeMichele, Claudine Isaacs, Jane Perlmutter, Joan Venticinque, Hope S Rugo, Richard Schwab, Nola M Hylton, W Fraser Symmans, Michelle E Melisko, Teresa L Helsten, Laura J van't Veer, Donald A Berry, Laura J Esserman
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS4-08.
https://doi.org/10.1158/1538-7445.SABCS20-PS4-08
Published: 15 February 2021
View articletitled, Abstract PS4-08: Biomarker analysis of paclitaxel, ganitumab, and metformin (PGM) therapy in the I-SPY2 neoadjuvant clinical trial
Journal Articles

Abstract PD6-02: Digital MammaPrint and BluePrint using machine learning and whole slide imaging

Annuska M Glas, Jorge S Reis-Filho, Diederik Wehkamp, Belma Dodgas, Leonie Delahaye, Ran Godrich, Jeroen Mollink, Adam Casson, Anke Witteveen, Julian Viret, Donghun Lee, Matthew Lee, Hugo Horlings, Leo Grady, Thomas Fuchs, William Audeh, Christopher Kanan, Laura J van't Veer
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD6-02.
https://doi.org/10.1158/1538-7445.SABCS20-PD6-02
Published: 15 February 2021
View articletitled, Abstract PD6-02: Digital MammaPrint and BluePrint using machine learning and whole slide imaging
Journal Articles

Abstract PD1-10: Evaluation of SGN-LIV1a followed by AC in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL

Heather Beckwith, Richard Schwab, Christina Yau, Erica Stringer-Reasor, Shi Wei, A. Jo Chien, Kathy S Albain, Kevin Kalinsky, Anne Wallace, Anthony Elias, Douglas Yee, Amy S Clark, Judy C Boughey, Heather Han, Rita Nanda, Claudine Isaacs, Zahi Mitri, Julie E Lang, Alexandra Thomas, Tara Sanft, Angela DeMichele, Jane Perlmutter, Hope S Rugo, Nola M Hylton, W. Fraser Symmans, Michelle E Melisko, Laura J van't Veer, I-SPY 2 Consortium, Amy Wilson, Smita M Asare, Ashish Sanil, Donald A Berry, Laura J Esserman
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD1-10.
https://doi.org/10.1158/1538-7445.SABCS20-PD1-10
Published: 15 February 2021
View articletitled, Abstract PD1-10: Evaluation of SGN-LIV1a followed by AC in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL
Journal Articles

Abstract CT011: Evaluation of durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL

Lajos Pusztai, Hyo S. Han, Christina Yau, Denise Wolf, Anne M. Wallace, Rebecca Shatsky, Teresa Helsten, Judy C. Boughey, Tufia Haddad, Erica Stringer-Reasor, Carla Falkson, A. Jo Chien, Rita Mukhtar, Anthony Elias, Borges Virginia, Rita Nanda, Douglas Yee, Kevin Kalinsky, Kathy S. Albain, Aixa Soyano Muller, Kathleen Kemmer, Amy S. Clark, Claudine Isaacs, Alexandra Thomas, Nola Hylton, W. Fraser Symmans, Jane Perlmutter, Michelle Melisko, Hope S. Rugo, Richard Schwab, Amy Wilson, Amy Wilson, Ruby Singhrao, Smita Asare, Laura J. van't Veer, Angela M. DeMichele, Ashish Sanil, Donald A. Berry, Laura J. Esserman, Trial Consortium I-SPY 2
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT011.
https://doi.org/10.1158/1538-7445.AM2020-CT011
Published: 15 August 2020
View articletitled, Abstract CT011: Evaluation of durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer: Results from the I-SPY 2 TRIAL
Journal Articles

Abstract P6-02-01: The effect of background parenchymal enhancement on the predictive performance of functional tumor volume measured in MRI

Wen Li, Natsuko Onishi, David C Newitt, Roy Harnish, Ella F Jones, Lisa J Wilmes, Jessica Gibbs, Elissa Price, Bonnie N Joe, A. Jo Chien, Donald A Berry, Judy C Boughey, Kathy S Albain, Amy S Clark, Kirsten K Edmiston, Anthony D Elias, Erin D Ellis, David M Euhus, Heather S Han, Claudine Isaacs, Qamar J Khan, Julie E Lang, Janice Lu, Jane L Meisel, Zaha Mitri, Rita Nanda, Donald W Northfelt, Tara Sanft, Erica Stringer-Reasor, Rebecca K Viscusi, Anne M Wallace, Douglas Yee, Rachel Yung, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, Richard Schwab, W. Fraser Symmans, Laura J van't Veer, Christina Yau, Smita M Asare, Angela DeMichele, Sally Goudreau, Hiroyuki Abe, Deepa Sheth, Dulcy Wolverton, Kelly Fountain, Richard Ha, Ralph Wynn, Erin P Crane, Charlotte Dillis, Theresa Kuritza, Kevin Morley, Michael Nelson, An Church, Bethany Niell, Jennifer Drukteinis, Karen Y Oh, Neda Jafarian, Kathy Brandt, Sadia Choudhery, Dae Hee Bang, Christiane Mullins, Stefanie Woodard, Kathryn W Zamora, Haydee Ojeda-Fornier, Mohammad Eghedari, Pulin Sheth, Linda Hovanessian-Larsen, Mark Rosen, Elizabeth S McDonald, Michael Spektor, Marina Giurescu, Mary S Newell, Michael A Cohen, Elise Berman, Constance Lehman, William Smith, Kim Fitzpatrick, Marisa H Borders, Wei Yang, Basak Dogan, Laura J Esserman, Nola M Hylton
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P6-02-01.
https://doi.org/10.1158/1538-7445.SABCS19-P6-02-01
Published: 15 February 2020
View articletitled, Abstract P6-02-01: The effect of background parenchymal enhancement on the predictive performance of functional tumor volume measured in MRI
Journal Articles

Abstract P6-10-02: Assessing biomarkers to inform treatment de-escalation: Mid-treatment biopsy cellularity predicts pCR in the I-SPY 2 Trial

Sara J Venters, Denise M Wolf, Lamorna Brown-Swigart, Christina Yau, Amy L Delson, Bev Parker, Ron Balassanian, Jodi Carter, Yunn-Yi Chen, Kimberly Cole, Laila Khazai, Molly Klein, Dina Kokh, Gregor Krings, Sunati Sahoo, Jane Wei, I-SPY 2 TRIAL Consortium, Laura J Esserman, Laura J van't Veer, W Fraser Symmans
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P6-10-02.
https://doi.org/10.1158/1538-7445.SABCS19-P6-10-02
Published: 15 February 2020
View articletitled, Abstract P6-10-02: Assessing biomarkers to inform treatment de-escalation: Mid-treatment biopsy cellularity predicts pCR in the I-SPY 2 Trial
Journal Articles

Abstract PD9-04: Breast cancer subtype specific association of pCR with MRI assessed tumor volume progression during NAC in the I-SPY 2 trial

Wen Li, Natsuko Onishi, David C Newitt, Jessica Gibbs, Lisa J Wilmes, Ella F Jones, Bonnie N Joe, Laura S Sit, Christina Yau, A. Jo Chien, Elissa Price, Kathy S Albain, Theresa Kuritza, Kevin Morley, Judy C Boughey, Kathy Brandt, Sadia Choudhery, Amy S Clark, Mark Rosen, Elizabeth S McDonald, Anthony D Elias, Dulcy Wolverton, Kelly Fountain, David M Euhus, Heather S Han, Bethany Niell, Jennifer Drukteinis, Julie E Lang, Janice Lu, Jane L Meisel, Zaha Mitri, Rita Nanda, Donald W Northfelt, Tara Sanft, Erica Stringer-Reasor, Rebecca K Viscusi, Anne M Wallace, Douglas Yee, Rachel Yung, Smita M Asare, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, Richard Schwab, W. Fraser Symmans, Laura J van't Veer, Donald A Berry, Angela DeMichele, Hiroyuki Abe, Deepa Sheth, Kirsten K Edmiston, Erin D Ellis, Richard Ha, Ralph Wynn, Erin P Crane, Charlotte Dillis, Michael Nelson, An Church, Claudine Isaacs, Qamar J Khan, Karen Y Oh, Neda Jafarian, Dae Hee Bang, Christiane Mullins, Stefanie Woodard, Kathryn W Zamora, Haydee Ojeda-Fornier, Pulin Sheth, Linda Hovanessian-Larsen, Mohammad Eghtedari, Michael Spektor, Marina Giurescu, Mary S Newell, Michael A Cohen, Elise Berman, Constance Lehman, William Smith, Kim Fitzpatrick, Marisa H Borders, Wei Yang, Basak Dogan, Sally Goudreau, Thelma Brown, Laura J Esserman, Nola M Hylton
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD9-04.
https://doi.org/10.1158/1538-7445.SABCS19-PD9-04
Published: 15 February 2020
View articletitled, Abstract PD9-04: Breast cancer subtype specific association of pCR with MRI assessed tumor volume progression during NAC in the I-SPY 2 trial
Journal Articles

Abstract P3-11-02: Evaluation of patritumab/paclitaxel/trastuzumab over standard paclitaxel/trastuzumab in early stage, high-risk HER2 positive breast cancer: Results from the neoadjuvant I-SPY 2 trial

Teresa L Helsten, Shelly S Lo, Christina Yau, Kevin Kalinsky, Anthony D Elias, Anne M Wallace, A. Jo Chien, Janice Lu, Julie E Lang, Kathy S Albain, Erica Stringer-Reasor, Amy S Clark, Judy C Boughey, Erin D Ellis, Douglas Yee, Angela DeMichele, Claudine Isaacs, Jane Perlmutter, Hope S Rugo, Richard Schwab, Nola M. Hylton, W. Fraser Symmans, Michelle E Melisko, Laura J van't Veer, Amy Wilson, Ruby Singhrao, Smita M Asare, Ashish Sanil, Donald A Berry, Laura J Esserman
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P3-11-02.
https://doi.org/10.1158/1538-7445.SABCS19-P3-11-02
Published: 15 February 2020
View articletitled, Abstract P3-11-02: Evaluation of patritumab/paclitaxel/trastuzumab over standard paclitaxel/trastuzumab in early stage, high-risk HER2 positive breast cancer: Results from the neoadjuvant I-SPY 2 trial
Journal Articles

Abstract P3-09-02: Evaluation of a novel agent plus standard neoadjuvant therapy in early stage, high-risk HER2 negative breast cancer: Results from the I-SPY 2 TRIAL

Minetta C. Liu, Patricia A Robinson, Christina Yau, Anne M Wallace, A. Jo Chien, Erica Stringer-Reasor, Rita Nanda, Douglas Yee, Kathy S Albain, Judy C Boughey, Heather S Han, Anthony D Elias, Kevin Kalinsky, Amy S Clark, Kathleen Kemmer, Claudine Isaacs, Julie E Lang, Janice Lu, Tara Sanft, Angela DeMichele, Nola M Hylton, Michelle E Melisko, Jane Perlmutter, Hope S Rugo, Richard Schwab, W. Fraser Symmans, Laura J van't Veer, Patricia K Haugen, Amy Wilson, Ruby Singhrao, Smita Asare, Ashish Sanil, Donald A Berry, Laura J Esserman
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P3-09-02.
https://doi.org/10.1158/1538-7445.SABCS19-P3-09-02
Published: 15 February 2020
View articletitled, Abstract P3-09-02: Evaluation of a novel agent plus standard neoadjuvant therapy in early stage, high-risk HER2 negative breast cancer: Results from the I-SPY 2 TRIAL
Journal Articles

Abstract PD9-05: Lack of background parenchymal enhancement suppression in breast MRI during neoadjuvant chemotherapy may be associated with inferior treatment response in hormone receptor positive breast cancer

Natsuko Onishi, Wen Li, David C. Newitt, Roy Harnish, Jessica Gibbs, Ella F. Jones, Alex Nguyen, Lisa Wilmes, Bonnie N. Joe, Michael J. Campbell, Amrita Basu, Laura J. van’t Veer, Angela DiMichele, Douglas Yee, Donald A. Berry, Kathy S. Albain, Judy C. Boughey, A. Jo Chien, Amy S. Clark, Kirsten K. Edmiston, Anthony D. Elias, Erin D. Ellis, David M. Euhus, Heather S. Han, Claudine Isaacs, Qamar J. Khan, Julie E. Lang, Janice Lu, Jane L. Meisel, Zaha Mitri, Rita Nanda, Donald W. Northfelt, Tara Sanft, Erica Stringer-Reasor, Rebecca K. Viscusi, Anne M. Wallace, Rachel Yung, Michelle E. Melisko, Jane Perlmutter, Hope S. Rugo, Richard Schwab, W. Fraser Symmans, Smita M. Asare, Julie E. Yau, Christina Yau, Laura J. Esserman, Nola M. Hylton
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD9-05.
https://doi.org/10.1158/1538-7445.SABCS19-PD9-05
Published: 15 February 2020
View articletitled, Abstract PD9-05: Lack of background parenchymal enhancement suppression in breast MRI during neoadjuvant chemotherapy may be associated with inferior treatment response in hormone receptor positive breast cancer
Journal Articles

Abstract LB-102: Landscape analysis of the initial data release from AACR Project GENIE

Ethan Cerami, Alexander S. Baras, Justin Guinney, Eva Lepisto, Trevor J. Pugh, Nikolaus Schultz, Thomas Stricker, Shawn M. Sweeney, Laura J. van't Veer, Gerrit A. Meijer, Fabrice Andre, Victor E. Velculescu, Kenna R. Shaw, Mia A. Levy, Philippe L. Bedard, Barrett J. Rollins, Charles L. Sawyers, on behalf of the AACR Project GENIE Consortium
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): LB-102.
https://doi.org/10.1158/1538-7445.AM2017-LB-102
Published: 01 July 2017
View articletitled, Abstract LB-102: Landscape analysis of the initial data release from AACR Project GENIE
Journal Articles

Abstract P4-11-12: MammaPrint accurately predicts long-term survival (25 years) and adjuvant tamoxifen therapy benefit in lymph node negative patients

Linda S Lindstrom, Christopher C Benz, Christina Yau, Laura J van't Veer, Carlie K Thompson, Laura J Esserman
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P4-11-12.
https://doi.org/10.1158/1538-7445.SABCS14-P4-11-12
Published: 01 May 2015
View articletitled, Abstract P4-11-12: MammaPrint accurately predicts long-term survival (25 years) and adjuvant tamoxifen therapy benefit in lymph node negative patients
Journal Articles

Abstract 4558: FDG-PET uptake in breast cancer molecular subtypes

Sjoerd G. Elias, Dorota J. Wisner, Yunn-Yi Chen, Spencer C. Behr, Ann Griffin, Laura J. Esserman, Laura J. van't Veer, Nola M. Hylton
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4558.
https://doi.org/10.1158/1538-7445.AM2012-4558
Published: 15 April 2012
View articletitled, Abstract 4558: FDG-PET uptake in breast cancer molecular subtypes
Journal Articles

Abstract 3696A: The detection and prediction of circulating tumor cells in breast cancer patients

Tim Molloy, Helgi H Helgason, Astrid Bosma, Laura J. van't Veer
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3696A.
https://doi.org/10.1158/1538-7445.AM2008-3696A
Published: 15 May 2008
View articletitled, Abstract 3696A: The detection and prediction of circulating tumor cells in breast cancer patients
Journal Articles

Do MDM2 SNP309 and TP53 R72P Interact in Breast Cancer Susceptibility? A Large Pooled Series from the Breast Cancer Association Consortium

Marjanka K. Schmidt, Scarlett Reincke, Annegien Broeks, Linde M. Braaf, Frans B.L. Hogervorst, Rob A.E.M. Tollenaar, Nichola Johnson, Olivia Fletcher, Julian Peto, Johanna Tommiska, Carl Blomqvist, Heli A. Nevanlinna, Catherine S. Healey, Alison M. Dunning, Paul D.P. Pharoah, Douglas F. Easton, Thilo Dörk, Laura J. Van't Veer, on behalf of the Breast Cancer Association Consortium
Journal: Cancer Research
Cancer Res (2007) 67 (19): 9584–9590.
https://doi.org/10.1158/0008-5472.CAN-07-0738
Published: 01 October 2007
View articletitled, Do MDM2 SNP309 and TP53 R72P Interact in Breast Cancer Susceptibility? A Large Pooled Series from the Breast Cancer Association Consortium
Open the PDF for Do MDM2 SNP309 and TP53 R72P Interact in Breast Cancer Susceptibility? A Large Pooled Series from the Breast Cancer Association Consortium in another window
Journal Articles

Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer

Britta Weigelt, Zhiyuan Hu, Xiaping He, Chad Livasy, Lisa A. Carey, Matthew G. Ewend, Annuska M. Glas, Charles M. Perou, Laura J. van't Veer
Journal: Cancer Research
Cancer Res (2005) 65 (20): 9155–9158.
https://doi.org/10.1158/0008-5472.CAN-05-2553
Published: 17 October 2005
View articletitled, Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer
Open the PDF for Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer in another window
Journal Articles

Factors influencing reproducibility of gene expression measurements using DNA microarrays.

Robert A. Ach, Arno Floore, Bo Curry, Annuska Glas, Rob Pover, Anya Tsalenko, Nick Sampas, Peter Tsang, Laurakay Bruhn, Laura J. Van’t Veer
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 102.
Published: 01 May 2005
View articletitled, Factors influencing reproducibility of gene expression measurements using DNA microarrays.
Journal Articles

Comparative Genomic Hybridization Profiles in Human BRCA1 and BRCA2 Breast Tumors Highlight Differential Sets of Genomic Aberrations

Erik H. van Beers, Tibor van Welsem, Lodewyk F.A. Wessels, Yunlei Li, Rogier A. Oldenburg, Peter Devilee, Cees J. Cornelisse, Senno Verhoef, Frans B.L. Hogervorst, Laura J. van't Veer, Petra M. Nederlof
Journal: Cancer Research
Cancer Res (2005) 65 (3): 822–827.
https://doi.org/10.1158/0008-5472.822.65.3
Published: 10 February 2005
View articletitled, Comparative Genomic Hybridization Profiles in Human BRCA1 and BRCA2 Breast Tumors Highlight Differential Sets of Genomic Aberrations
Open the PDF for Comparative Genomic Hybridization Profiles in Human BRCA1 and BRCA2 Breast Tumors Highlight Differential Sets of Genomic Aberrations in another window
Journal Articles

Large Genomic Deletions and Duplications in the BRCA1 Gene Identified by a Novel Quantitative Method

Frans B. L. Hogervorst, Petra M. Nederlof, Johan J. P. Gille, Cathal J. McElgunn, Maartje Grippeling, Roelof Pruntel, Rein Regnerus, Tibor van Welsem, Resie van Spaendonk, Fred H. Menko, Irma Kluijt, Charlotte Dommering, Senno Verhoef, Jan P. Schouten, Laura J. van’t Veer, Gerard Pals
Journal: Cancer Research
Cancer Res (2003) 63 (7): 1449–1453.
Published: 01 April 2003
View articletitled, Large Genomic Deletions and Duplications in the BRCA1 Gene Identified by a Novel Quantitative Method
Open the PDF for Large Genomic Deletions and Duplications in the BRCA1 Gene Identified by a Novel Quantitative Method in another window